Health authorities in Weymouth have confirmed three cases of meningitis among young people, prompting officials to offer MenB vaccines as a precautionary measure.

The cases were identified in the coastal town in Dorset, England, though specific details about the patients' ages and conditions have not been disclosed by health officials. Meningitis is a serious infection that causes inflammation of the protective membranes covering the brain and spinal cord.

In response to the outbreak, local health services are making the MenB vaccine available to young people in the area. The MenB vaccine protects against meningococcal group B bacteria, which is one of the most common causes of bacterial meningitis in the United Kingdom.

Meningococcal disease can develop rapidly and can be life-threatening if not treated promptly. Early symptoms often include fever, headache, neck stiffness, and a distinctive rash that does not fade under pressure.

Health officials typically recommend vaccination campaigns when multiple cases occur in a localized area to prevent further spread of the infection. The MenB vaccine has been part of the routine UK childhood immunization program since 2015 for infants, but additional doses may be offered during outbreak situations.